Bone Marrow TransplantationTransplantation, AutologousBone MarrowBone Marrow CellsTransplantation, HomologousCombined Modality TherapyGraft vs Host DiseaseBone and BonesWhole-Body IrradiationBone Marrow PurgingTissue DonorsTransplantation ChimeraAntineoplastic Combined Chemotherapy ProtocolsGraft SurvivalLeukemiaTransplantation ConditioningHematopoietic Stem Cell TransplantationAnemia, AplasticHematopoietic Stem CellsHistocompatibility TestingCyclophosphamideHistocompatibilityBone Marrow DiseasesBusulfanLymphoma, Non-HodgkinRecurrenceBone RemodelingBone Marrow ExaminationTreatment OutcomeHematopoiesisRadiation ChimeraLeukemia, Myeloid, AcuteGraft RejectionTransplantation, IsogeneicMice, Inbred C57BLImmunosuppressive AgentsPrecursor Cell Lymphoblastic Leukemia-LymphomaTime FactorsBone Marrow NeoplasmsCarmustineImmunosuppressionColony-Forming Units AssayRemission InductionLeukemia, Myelogenous, Chronic, BCR-ABL PositiveKidney TransplantationActuarial AnalysisSurvival AnalysisMelphalanAcute DiseaseLeukemia, MyeloidBone DensityT-LymphocytesHLA AntigensLymphocyte DepletionHematologic NeoplasmsLeukocyte TransfusionHodgkin DiseaseTransplantation ToleranceGraft Enhancement, ImmunologicEtoposideCytomegalovirus InfectionsStem Cell TransplantationBone ResorptionHematologic DiseasesLiver TransplantationTransplantation ImmunologyRetrospective StudiesHepatic Veno-Occlusive DiseaseMyelodysplastic SyndromesDisease-Free SurvivalCytarabineCyclosporineCell DifferentiationSkin TransplantationHeart TransplantationChimerismFollow-Up StudiesLeukocyte CountMultiple MyelomaGraft vs Host ReactionFlow CytometryChimeraSurvival RateGranulocyte Colony-Stimulating FactorMice, Inbred BALB CCells, CulturedBone NeoplasmsAntigens, CD34LymphomaBone TransplantationGranulocytesLymphocyte TransfusionLymphocyte Culture Test, MixedOpportunistic InfectionsCell SeparationThiotepaSpleenImmunocompromised HostNuclear FamilyBone Development